MedTrace Logo

The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy

NCT06218537 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-11-12

No results posted yet for this study

Summary

The investigators aim to establish wether the administration of pancreatic enzyme replacement therapy (PERT) improves visibility of the mucosa during upper gastrointestinal endoscopy.

Conditions

  • Upper Gastrointestinal Endoscopy

Interventions

DIAGNOSTIC_TEST

Test group

Contains protease from KREON capsules, activated by adding sodium bicarbonate.

DIAGNOSTIC_TEST

Control group

Contains only sodium bicarbonate.

Sponsors & Collaborators

  • Carol Davila University of Medicine and Pharmacy

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06218537 on ClinicalTrials.gov